In mesothelioma, Fridlender et al. tested monocyte chemoattractant protein-1 (MCP-1/CCL2) blockade in a mouse model for mesothelioma and demonstrated an altered macrophage phenotype and improved survival. Here, CCL2 is linked to mesothelioma.